Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01964209 · ClinicalTrials.gov registry record

Initial Validation of the Vanderbilt ADHD Measure for Adolescent Patients in the ICISS Project

A clinical trial of ADHD, sponsored by Boston Children's Hospital.

Completed
Registry status
48
Enrollment target
1
Study location

NCT01964209: Completed study of ADHD, sponsored by Boston Children's Hospital.

NCT01964209 is a study of ADHD that has completed, run by Boston Children's Hospital. The registered enrollment target is 48 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01964209, a study of ADHD, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
48 participants
Enrollment target
1
Study location

Study Summary

This proposal is to evaluate the reliability and validity of the Vanderbilt ADHD screening tool for use with adolescents and young adults aged 13-21 years. The Vanderbilt is a previously developed, freely available set of parent- and teacher-report questionnaires designed to identify ADHD and related disorders in children. The Vanderbilt measures have been chosen for inclusion in the new computerized Integrated Clinical Information Sharing System (ICISS) being rolled out in five Boston Children's Hospital (BCH) departments/divisions (Adolescent/Young Adult Practice, Children's Hospital Primary Care Center, Developmental Medicine Center, Department of Neurology, Department of Psychiatry). The Vanderbilt was developed and validated for use among children up to age 12 years (Wolraich et al., 2003; Wolraich et al., 2013; Bard et al., 2013), and little is known about its appropriateness for use among older youth. In addition, there is no self-report version of the Vanderbilt that can be administered directly to adolescents and young adults (ages 13-21 years), for whom parents and teachers are often less knowledgeable reporters. To address these shortcomings, a multidisciplinary team of BCH adolescent health clinicians and researchers modified the parent and teacher Vanderbilt questionnaires to make them age-appropriate for adolescents and young adults and created a complementary self-report version for adolescents and young adults. The goal of the current study is to 1) assess the feasibility and acceptability of online administration through the ICISS system of the new parent, teacher, and youth self-report Vanderbilt measures among adolescent and young adult BCH patients aged 13-21 years; 2) test their reliability in terms of internal consistency reliability, temporal stability of responses over a one-month test-retest, and inter-rater agreement across all informants (parents, teachers, and youths); and 3) test their validity by evaluating their convergence with a simi

Primary Outcome

We will assess for each measure the level of internal consistency reliability, temporal stability of responses over a one-month test-retest, and inter-rater agreement across all informants (parents, teachers, and youths).

Conditions Studied

Study Locations (1)

Massachusetts

  • Boston Children's Hospital, Adolescent/ Young Adult Clinic - Boston

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2014-05
Est. Completion 2018-11-15
Boston Children's Hospital

462 total trials

What the finished NCT01964209 record still lists

NCT01964209 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (75% lower).

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 0 interventions.

NCT01964209 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01964209 about?

NCT01964209 is a clinical study titled "Initial Validation of the Vanderbilt ADHD Measure for Adolescent Patients in the ICISS Project". This proposal is to evaluate the reliability and validity of the Vanderbilt ADHD screening tool for use with adolescents and young adults aged 13-21 years. The Vanderbilt is a previously developed, freely available set of parent- and teacher-report questionnaires designed to identify ADHD and relate...

What is the current status of trial NCT01964209?

This trial is currently completed. The enrollment target is 48 participants. The study started on 2014-05. Estimated completion is 2018-11-15.

What conditions does trial NCT01964209 study?

This clinical trial studies the following conditions: ADHD.

Who is sponsoring clinical trial NCT01964209?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01964209 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01964209's enrollment target sits among peer trials

48 49th of 75 higher than 26 of 75 other ADHD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01964209, the US trial registry maintained by the National Library of Medicine. NCT01964209 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.